Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.
Cancer Center Studies Lead to New Trials for Malignant Melanoma Treatment — Breast cancer drug Abraxane promising for metastatic malignant melanoma treatment. – An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.
JNCI news brief: Thalidomide does not improve survival in small cell lung cancer – Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.
ASTRO issues consensus statement on using APBI to treat breast cancer – A new consensus statement outlining patient selection criteria and best practices for the use of accelerated partial breast irradiation (APBI) outside the context of a clinical trial has been published in the July 15 issue of the International Journal of Radiation Oncology Biology Physics.
Research identifies network of altered genes that appear to play role in development of brain tumors – The interaction between a network of altered genes appears to play an important role in the development and progression of brain tumors, revealed by researchers in the Journal of the American Medical Association — JAMA.
Regardless of the duration of use, the formulation, estrogen dose, regimen, progestin type, and route of administration, hormone therapy was associated with an increased risk of ovarian cancer. – Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.
Heavy, daily drinking increases risk of high-grade prostate cancer; makes preventive drug ineffective. – In a new study, researchers examined the associations of total alcohol, type of alcoholic beverage, and drinking pattern with risks of total, low- and high-grade prostate cancer.
Australian researchers identify genes that cause melanoma – Two new genes that together double a person’s risk of developing melanoma are identified by researchers from the Queensland Institute of Medical Research (QIMR), Australia.
Researchers find genetic key to breast cancer’s ability to survive and spread – New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
Moles and melanoma — researchers find genetic links to skin cancer – Why people with the greatest number of moles are at increased risk of the most dangerous form of skin cancer, this puzzle is solved by UK researchers. Their findings are published in the journal Nature Genetics.
U.S. Food and Drug Administration (FDA) approves first maintenance drug therapy for advanced lung cancer — Alimta, pemetrexed. – Eli Lilly’s lung cancer drug Alimta (pemetrexed) — the first drug available for maintenance therapy of advanced or metastatic lung cancer, is approved by the U.S. Food and Drug Administration, USA.
Report: Prostate cancer screening has yet to prove its worth – The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
Selenium intake may worsen prostate cancer in some, study reports – Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, revealed by researchers.
